Can Hypofractionation and Immune Modulation Coexist? An editorial on the article “Phase I Trial of Atezolizumab plus Trimodal Therapy in Patients with localized Muscle-Invasive Bladder Cancer”

Richard C. Walshaw, Peter J. Hoskin, Ananya Choudhury

Research output: Contribution to journalEditorialpeer-review

8 Downloads (Pure)
Original languageEnglish
Pages (from-to)742-744
JournalInternational Journal of Radiation: Oncology - Biology - Physics
Volume110
Issue number3
Early online date2 Jun 2021
DOIs
Publication statusPublished - 1 Jul 2021

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this